Compare · CTEV vs RELX
CTEV vs RELX
Side-by-side comparison of Claritev Corporation (CTEV) and RELX PLC PLC (RELX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CTEV and RELX operate in Real Estate (Real Estate), so they compete in similar markets.
- RELX is the larger of the two at $65.44B, about 102.6x CTEV ($637.9M).
- CTEV has been more active in the news (9 items in the past 4 weeks vs 2 for RELX).
- RELX has more recent analyst coverage (12 ratings vs 6 for CTEV).
- Company
- Claritev Corporation
- RELX PLC PLC
- Price
- $37.52+3.33%
- $35.88-1.41%
- Market cap
- $637.9M
- $65.44B
- 1M return
- -
- +0.69%
- 1Y return
- -
- -25.05%
- Industry
- Real Estate
- Real Estate
- Exchange
- NYSE
- NYSE
- IPO
- 2020
- 2015
- News (4w)
- 9
- 2
- Recent ratings
- 6
- 12
RELX PLC PLC
RELX PLC provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Scientific, Technical & Medical; Risk; Legal; and Exhibitions. The Scientific, Technical & Medical segment provides information and analytics that help institutions and professionals to progress in science and advance healthcare. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as enhance the productivity. The Exhibitions segment is involved in the events business. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
Latest CTEV
- SVP, Chief Growth Officer Misencik Tiffani sold $354,593 worth of shares (8,850 units at $40.07), decreasing direct ownership by 7% to 123,723 units (SEC Form 4)
- Marpai Expands Relationship with Claritev to Help Reduce Healthcare Costs for Employer Clients
- SVP, Chief Strategy Officer Mintz William B. sold $288,677 worth of shares (8,431 units at $34.24), decreasing direct ownership by 11% to 71,195 units (SEC Form 4)
- SVP, Chief Strategy Officer Mintz William B. covered exercise/tax liability with 3,622 shares, decreasing direct ownership by 4% to 79,626 units (SEC Form 4)
- EVP&CFO Garis Douglas Michael covered exercise/tax liability with 11,711 shares, decreasing direct ownership by 6% to 194,441 units (SEC Form 4)
- SEC Form 10-Q filed by Claritev Corporation
- Claritev Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Claritev Corporation Reports Second Quarter 2026 Results
- Claritev Corporation Announces Participation in Canaccord Genuity 46th Annual Growth Conference
- Claritev Demonstrates Market Leadership as Federal No Surprises Act Disputes Reach Record Levels
Latest RELX
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- 2026 LexisNexis U.S. Home Insurance Trends Report: Claims Severity Reaches All-Time High While Frequency Declines
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC
- SEC Form 6-K filed by RELX PLC PLC